Zoetis Cattlemaster 4+vl5 Vaccine - 10 Dose

For beef cattle producers, cattlemaster 4 + vl5 helps protect against four major viral respiratory diseases of cattle, plus protection against campylobacteriosis (vibriosis) and five common strains of leptospira.

Features

• For use with beef

Indications

For vaccination of healthy cattle, including pregnant cows, to protect against four major respiratory pathogens: infectious bovine rhinotracheitis (ibr) virus, bovine viral diarrhea (bvd) type 1 virus, parainfluenza3 (pi3) virus, and bovine respiratory syncytial virus (brsv). Also protects against reproductive disease caused by campylobacter fetus, and leptospirosis caused by leptospira canicola, l. Grippotyphosa, l. Hardjo, l. Icterohaemorrhagiae, and l. Pomona.

How It's Works

Cattlemaster 4 + Vl5 Is A Freeze-dried Preparation Of Chemically Altered Strains Of IBR And Pi3 Viruses And Modified-live BRSV Plus A Liquid Adjuvanted Preparation Of Inactivated Cytopathic And Noncytopathic BVD Type 1 Virus Strains, C. Fetus, And Cultures Of The Five Common Leptospira Serovars. The Liquid Component Is Used To Rehydrate The Freeze-dried Component. Viral Antigens Are Propagated On An Established Cell Line. This Product Is Adjuvanted With The Aluminum Hydroxide To Enhance Immune Response.

Safety Information

• Store at 2 - 7°c. Prolonged exposure to higher temperatures and/or direct sunlight may adversely affect potency. Do not freeze
• Use entire contents when first opened
• Sterilized syringes and needles should be used to administer this vaccine. Do not sterilize with chemicals because traces of disinfectant may inactivate the vaccine
• Burn containers and all unused contents
• Do not vaccinate within 21 days before slaughter
• Contains gentamicin as preservative
• Occasional hypersensitivity reactions may occur up to 18 hr postvaccination. Owners should be advised to observe animals during this period. While this event appears to be rare overall, dairy cattle may be affected more frequently than other cattle. Animals affected may display excessive salivation, incoordination, and/or dyspnea. Animals displaying such signs should be treated immediately with epinephrine or equivalent. In nonresponsive animals, other modes of treatment should be considered
As with many vaccines, anaphylaxis may occur after use. An initial antidote of epinephrine is recommended and should be followed with appropriate supportive therapy
• This product has been shown to be efficacious in healthy animals. A protective immune response may not be elicited if animals are persistently infected with bvd virus or incubating an infectious disease, are malnourished or parasitized, are stressed due to shipment or environmental conditions, are otherwise immunocompromised, or the vaccine is not administered in accordance with label directions

Specifications

• Size: 10 Dose